Network Pharmacology in Modern Drug Discovery and Development

Abstract

The "one drug, one target, one disease" philosophy has traditionally dominated the process of drug discovery. Successful in instances of cancers, Alzheimer's, diabetes, and cardiovascular diseases, it has fallen short for multifactorial diseases with multiple molecular pathways and biological networks being involved simultaneously. Network pharmacology has been a pioneering strategy that marries systems biology, computational models, bioinformatics, and multi-omics tools to study drug–target–disease interactions from a comprehensive outlook. By moving from single-target therapy to multi-target and multi-pathway modulation, it sheds new light on disease mechanisms as well as therapeutic interventions. Network pharmacology is critical to target identification, drug repurposing, and rational multi-target drug design, greatly facilitating the process of drug discovery while containing costs. Coupling with artificial intelligence, pharmacogenomics, and big data analytics further strengthens its predictive ability and clinical utility. It is also helpful in validating natural products, traditional medicines, and combination therapies through network-based systems. In spite of challenges like data quality, complexity of the network, and translational gaps, network pharmacology is a paradigm shift in contemporary drug discovery and personalized medicine, promising safer, more effective, and patient-specific therapeutic approaches.